This quiz explores key aspects of mental health disorders such as PTSD, OCD, and anxiety disorders, focusing on diagnosis, symptoms, and treatment options including pharmacotherapy and cognitive-behavioral therapy. It is designed to assess understanding and application of treatment protocols for different demographics.
Most common all psychiatric disorder
More common in men than women
Can be secondary to medication
Commonly comorbid with other disease states
Rate this question:
COPD
Hypertensive crisis
Prolonged QT
Sudden Death
Rate this question:
Diazepam (Valium ®)
Clorazepate (Tranzene ®)
Lorazepam (Ativan ®)
Rate this question:
Hypotension
Prolonged QT
Seizures
Sudden death
Rate this question:
True
False
Rate this question:
True
False
Rate this question:
True
False
Rate this question:
8-12 weeks; 4-6 weeks
13-20 weeks ; 8-12 weeks
Rate this question:
True
False
Rate this question:
True
False
Rate this question:
Avoidance Symptoms
Depressive Symptoms
Hyperarousal Symptoms
Re-experiencing Symptoms
Rate this question:
Are excreted unchanged, primarily through urine
BZDs are lipophilic leading to increased half-lives in older adults
Carry a risk of cognitive impairment with long-term use
Risk associated with withdrawal/rebound symptoms are associated with high doses, but can occur at therapeutic doses as well
Rate this question:
True
False
Rate this question:
Elderly patients are less sensitive to the CNS effects of benzodiazepines
Elderly patients have an decreased fat to lean tissue ratio
Temazepam is metabolized via phase II metabolism so it is a preferred choice due to decreased CYP metabolism with advanced age
The same dose of benzodiazepines may be used in elderly patients, just monitor CNS effects and adjust dose accordingly
Rate this question:
Amitriptyline
Citalopram
Clomipramine
Fluoxetine
Rate this question:
Diazepam has the widest range of indications
Oxazepam has no active metabolites
Flumazenil is a competitive agonist of BZD at the BZ receptor
Zolpidem is a selective BZ1 agonist
Rate this question:
1st line ; 1st line
1st line ; 2nd line
2nd line ; 1st line
2nd line ; 2nd line
Rate this question:
Long-acting acting benzodiazepines are associated with no significant rebound insomnia while short-acting are associated with moderate rebound insomnia
Short-acting acting benzodiazepines are associated with no significant rebound insomnia while long-acting are associated with moderate rebound insomnia
Both long- and short-acting benzodiazepines are associated with no significant rebound insomnia
Both long- and short-acting benzodiazepines are associated with moderate significant rebound insomnia
Rate this question:
CBT + amitriptyline
CBT + paroxetine
CBT + sertraline
None of the above, the risk of suicidality associated with SSRIs is too great in adolescents. CBT should be used alone.
Rate this question:
Escitalopram
Paroxetine
Venlafaxine ER
Venlafaxine IR
Duloxetine
Rate this question:
Acts on GABA receptors involved with fear/anxiety
Are structurally related to BZD, but have completely different mechanism of action
Have slower onset of effects than BZD
Have higher abuse potential than BZD
More convenient dosing schedule
Rate this question:
2-4 weeks
6-8 weeks
10-12 weeks
12-16 weeks
Rate this question:
Taper 10% every week
Taper 25% every week
Taper 25% over 2-3 weeks
Taper 50% over 2-3 weeks
Rate this question:
Sertraline
Paroxetine
SSRI + atypical antipsychotic titrated to severity
Venlafaxine ER (Effexor XR)
Either A or B
None of the above/Other
Rate this question:
Alprazolam
Chlordiazepoxide
Lorazepam, Oxazepam, Temazepam
Triazolam
Clonazepam
Diazepam
Flurazepam
Rate this question:
Citalopram
Clomipramine
Fluoxetine
Fluvoxamine
Sertraline
Rate this question:
Quiz Review Timeline (Updated): Mar 21, 2023 +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
Wait!
Here's an interesting quiz for you.